Many patients worry they can “run out of sperm.” In reality, sperm production is continuous for most people with testes, but sperm output and even semen volume can change for predictable biologic reasons—and for treatable medical reasons. This long-form guide explains spermatogenesis, what’s in an ejaculate, how to interpret semen analysis, and what it means when sperm or semen is absent.
Medical note: This is educational information for patients and healthcare professionals. Evaluation and treatment decisions should be individualized.
Can you run out of sperm?
Most people with testes do not “run out” of sperm in the way that people with ovaries can “run out” of eggs. In healthy adult men, sperm are produced continuously in the testes after puberty and can continue into older age. One reason this is possible is that spermatogenesis is sustained by a stem cell pool of spermatogonia that replenishes itself while also generating cells that differentiate toward mature sperm. [1]
A helpful way to explain this to patients is: sperm production is a manufacturing process, not a one-time inventory. You can temporarily “empty the warehouse” (the stored sperm in the epididymis/vas deferens) with frequent ejaculation, but the “factory line” continues to run unless something disrupts it. This is why abstinence time changes semen analysis results, and why frequent ejaculation can reduce semen volume or total motile sperm count for a short period—without permanently depleting sperm production. [2]
That said, some people can have sperm counts that drop very low or to zero (azoospermia) because of medical conditions that impair sperm production, block sperm delivery, or change ejaculation. Importantly, these scenarios are usually described as: – Impaired sperm production (testicular/spermatogenic failure). – Obstruction (sperm are produced but cannot enter the semen). – Ejaculatory disorders (sperm/semen are produced but don’t come out normally). [3]
For patient counseling, it is also useful to normalize that sperm are routinely produced in very large numbers. Reviews commonly cite estimated daily sperm production in the hundreds of millions per day in healthy adult men (estimates vary by method and population). [4]
A question that often follows is: “If I don’t ejaculate, does sperm build up?” The epididymis has limited storage capacity, and unused sperm ultimately break down and are cleared. The exact quantitative clearance pathways in humans are complex and still actively studied; evidence across mammals suggests multiple mechanisms beyond simple “phagocytosis of all surplus sperm,” and the human-specific details are not fully settled. [5]
How spermatogenesis works
Spermatogenesis is the process by which diploid germ cells become highly specialized haploid spermatozoa. Clinically, the key point is that spermatogenesis is slow, exquisitely regulated, and sensitive to systemic illness, heat, toxins, hormonal disruption, and testicular injury. [6]
Where spermatogenesis happens
Spermatogenesis occurs within the seminiferous tubules of the testes. The seminiferous epithelium contains: – Germ cells at multiple developmental stages. – Sertoli cells, which orchestrate germ cell development, support, nutrition, and the microenvironment. – A surrounding interstitium containing Leydig cells that produce testosterone and support spermatogenesis via endocrine and paracrine pathways. [7]
For clinicians: This cellular architecture is why testicular pathology can present as isolated sperm production failure even when testosterone is relatively preserved (and vice versa), and why hormonal patterns (FSH/LH/testosterone) are informative but not perfectly diagnostic. [8]
The “clock” of sperm production
Patients often ask when a change (stopping testosterone, treating a varicocele, recovering from fever, lifestyle changes) will show up on semen analysis. The biologic rationale: new ejaculated sperm reflect testicular events from weeks to months earlier.
Classic work describing the kinetics of human spermatogenesis reports: – The seminiferous epithelium cycles approximately every ~16 days. – Development from spermatogonium to mature spermatid is roughly ~74 days. – Additional transit through the epididymis adds approximately ~12 days. [9]
This supports the common clinical teaching: meaningful changes in semen parameters often take ~3 months to fully manifest after an exposure or intervention. [10]
Endocrine regulation
Spermatogenesis is governed by the hypothalamic–pituitary–testicular axis: – GnRH drives pituitary secretion of LH and FSH. – LH stimulates Leydig cells to produce testosterone. – FSH acts largely on Sertoli cells to support germ cell development. – Testosterone is indispensable for quantitatively normal sperm production, and FSH contributes importantly to optimal spermatogenesis and Sertoli cell function. [11]
This is the physiologic basis for two practical counseling points: 1. Exogenous testosterone (including anabolic steroids) can suppress LH/FSH and shut down intratesticular testosterone signaling needed for spermatogenesis—sometimes resulting in severe oligospermia or azoospermia. [12]
2. In selected cases of hypogonadotropic hypogonadism, gonadotropin therapy can restore spermatogenesis because it replaces missing LH/FSH signaling. [13]
Heat, toxins, and medical treatments
Spermatogenesis is temperature-sensitive. Increased scrotal temperature has been associated with reduced sperm concentration and other adverse semen parameters, and controlled studies of scrotal hyperthermia have reported effects on sperm DNA integrity and apoptosis. [14]
Cancer therapies are a major “high-stakes” example. Chemo- and radiotherapy can reduce sperm counts—often to azoospermic levels—with recovery that may take years or may be incomplete, depending on agent and dose and on whether stem spermatogonia survive. [15]
What is in an ejaculate?
Patients commonly use “sperm,” “semen,” and “ejaculate” interchangeably. Clinically and physiologically, they are different: – Spermatozoa are the male gametes. – Semen (ejaculate fluid) is spermatozoa suspended in seminal plasma plus other cellular elements. – The ejaculate is the semen that is expelled during ejaculation. [16]
A striking but useful fact: sperm cells are a minority of semen volume. A review of seminal fluid characterization notes spermatozoa on the order of a few percent of volume, while most volume is glandular secretions that support sperm function and survival. [17]
Which organs contribute what?
Across physiologic reviews, the dominant contributors to semen volume are: – Seminal vesicles: the largest fraction, often cited around ~65–75% (or similar ranges depending on method and timing/fractionation). – Prostate: typically ~25–30%. – Vas deferens/epididymal contribution: a small fraction by volume but contains the spermatozoa. – Bulbourethral (Cowper’s) glands: a small fraction (often <1–2%). [18]
These aren’t merely “volume trivia.” They help interpret semen analysis patterns: – Low volume semen can reflect incomplete collection, partial retrograde ejaculation, androgen deficiency, or structural obstruction/agenesis affecting seminal vesicles/ejaculatory ducts. [19] – Acidic pH and absent fructose can suggest absent/obstructed seminal vesicle contribution (for example, ejaculatory duct obstruction or congenital anomalies), while other patterns suggest different etiologies. [20]
Semen coagulation and liquefaction
Fresh semen typically coagulates soon after ejaculation and then liquefies. This is not just an odd observation; it reflects coordinated gland function: – Seminal vesicle proteins semenogelins (with fibronectin) contribute to the post-ejaculation gel/coagulum. [21] – The prostate secretes serine proteases (including PSA) that cleave semenogelins, driving liquefaction and release of motile sperm. [22]
For patients: if a semen sample stays very thick and never liquefies, labs document this because it can make analysis difficult and can be associated with infertility in some contexts (though it is not a diagnosis by itself). [23]
Ejaculation vs orgasm
A critical counseling issue—especially when addressing “no semen comes out”—is that ejaculation and orgasm are related but distinct: – Orgasm is a central nervous system event (subjective sensation of climax). – Ejaculation is the physical process of expelling semen and is typically concurrent with orgasm but can be dissociated (orgasm without antegrade ejaculation, or ejaculation-like contractions without semen). [24]
Physiologically, ejaculation is usually described as two coordinated phases: – Emission: movement and mixing of secretions (epididymis/vas deferens, seminal vesicles, prostate, bulbourethral glands) into the prostatic urethra, with bladder neck closure to prevent semen flowing backward. – Expulsion (ejection): rhythmic contraction of pelvic and perineal muscles to propel semen through the urethra and out the meatus. [24]
Semen analysis: what is measured and what is “normal”?
A semen analysis is best viewed as a structured description of: 1. The ejaculate environment (volume, pH, viscosity/liquefaction, appearance). 2. The sperm population (concentration, total number, motility, vitality, morphology). 3. Additional context (round cells, leukocytes, agglutination, sometimes accessory gland markers). [25]
Why “normal ranges” are not fertility guarantees
Both patients and clinicians can over-interpret a “normal” result or panic over a “borderline” one. Two key principles from major guidance: – Semen parameters vary substantially from sample to sample; repeating testing is often needed when abnormal. [26] – The lower reference limits are percentiles from a reference population, not a bright line separating fertile from infertile. The World Health Organization[27] explicitly cautions against interpreting the lower fifth percentile as a fertility/infertility cutoff. [28]
WHO sixth edition reference values
The most widely used published reference distributions remain those compiled around natural conception cohorts. In the sixth edition WHO manual, the fifth percentile values listed for commonly reported parameters include: semen volume 1.4 mL, sperm concentration 16 million/mL, total sperm number 39 million/ejaculate, total motility 42%, progressive motility 30%, vitality 54%, and normal morphology 4%(strict criteria), among others. [29]
For practical use (and for patient communication), it is often clearer to present these as lower reference limits rather than “normal vs abnormal.”
Commonly cited WHO lower reference limits (5th percentile, sixth edition distributions): [29]
– Semen volume: ≥ 1.4 mL
– Sperm concentration: ≥ 16 million/mL
– Total sperm number: ≥ 39 million/ejaculate
– Total motility (progressive + non-progressive): ≥ 42%
– Progressive motility: ≥ 30%
– Vitality: ≥ 54%
– Morphology (normal forms, strict): ≥ 4%
For clinicians: It can be helpful to remind patients that “above the fifth percentile” means “within the broad range seen in men whose partners conceived within a defined timeframe,” not “guaranteed fertility.” [30]
What labs evaluate beyond the headline numbers
Even if the report emphasizes concentration and motility, most standardized workflows include steps that occur at defined times after collection. The WHO manual lays out a temporal outline: parameters that cannot be delayed (e.g., motility assessment) are prioritized, while others (like morphology staining) can occur later the same day or after smear preparation, depending on laboratory workflow. [31]
This matters for counseling about transport time: a “late” specimen can disproportionately affect motility and related derived metrics (e.g., total motile count), even if concentration is relatively stable. [32]
What happens when sperm is not produced or not present in semen?
When patients hear “zero sperm,” they often assume they have “run out,” or that ejaculation is impossible. Clinically, there are several distinct scenarios that look similar to a patient but differ profoundly in cause and management.
Azoospermia: absent sperm in the ejaculate
In major infertility guidance, azoospermia is defined as no sperm in the ejaculate, including after examination of a centrifuged semen pellet. [26]
Two high-level categories are emphasized across guidelines: – Obstructive azoospermia (OA): sperm are produced but cannot reach the ejaculate because of blockage or congenital absence of ducts (e.g., vas deferens).
– Non-obstructive azoospermia (NOA): sperm production is severely impaired; ejaculate volume is often normal because accessory glands still contribute fluid. [33]
From the patient standpoint, both OA and NOA can still have normal orgasm and ejaculation of fluid; the difference is whether sperm are present in that fluid. [34]
Distinguishing impaired production from obstruction
Specialists typically use a combination of: – Semen analysis patterns (volume, pH, presence/absence of sperm). – Physical exam (testicular size, presence of vas deferens). – Hormones (especially FSH and testosterone). [35]
For clinicians: the American Society for Reproductive Medicine[36] guideline summary emphasizes that azoospermic men should be evaluated to differentiate obstruction from impaired production using semen volume, physical exam, and FSH initially. [37]
Additional testing often includes genetic evaluation in selected cases (e.g., karyotype, Y-chromosome microdeletions, CFTR testing for suspected congenital obstructive etiologies), consistent with international guidance. [38]
Causes of impaired sperm production
For a blog geared to both patients and clinicians, it is useful to group causes into “pre-testicular,” “testicular,” and “post-testicular” frameworks, while emphasizing that real patients often have overlapping contributors.
Common evidence-based categories include: – Hormonal (pre-testicular): hypogonadotropic hypogonadism and other endocrine disorders. [39]
– Primary testicular dysfunction: congenital or acquired damage to seminiferous epithelium, including genetic syndromes, cryptorchidism history, varicocele-associated dysfunction, infection, trauma, and idiopathic severe spermatogenic failure. [40]
– Gonadotoxic exposure: chemo/radiotherapy with variable recovery depending on dose and agent. [15]
– Medication exposures: especially exogenous androgens/anabolic steroids suppressing gonadotropins. [12]
For patients: a key reassurance is that “zero sperm in semen” does not automatically mean “no testosterone,” “no orgasm,” or “no sex life.” These functions can be independent, though some causes overlap (for example, severe testicular failure can include low testosterone). [39]
What happens when semen does not come out with orgasm?
Many patients describe this as “dry orgasm” or “nothing came out.” Clinically, several distinct terms matter, because they map to different anatomy and management.
Clarifying terms: retrograde, antegrade, anejaculation, and aspermia
Patients asked about “retrograde ejaculation, great ejaculation, and an ejaculation.” In clinical terminology, the likely intended terms are antegrade ejaculation and anejaculation.
- Antegrade ejaculation: semen is expelled forward through the urethra (the usual direction). The bladder neck closes during emission so semen does not enter the bladder. [41]
- Retrograde ejaculation: partial or total absence of antegrade ejaculation because semen passes backward through the bladder neck into the bladder. [42]
- Anejaculation: complete absence of antegrade and retrograde ejaculation; in the European Association of Urology[43] guidance, it is attributed to failure of semen emission from seminal vesicles, prostate, and ejaculatory ducts into the urethra, often with preserved orgasmic sensation and associated with neurologic dysfunction or drugs. [44]
- Aspermia: a “dry ejaculate” in which little or no semen is produced/expelled; reviews describe this as potentially due to inability to transport semen (anejaculation) or inability to ejaculate in an antegrade direction (retrograde ejaculation). [45]
A practical counseling phrase: “Dry orgasm is a symptom; retrograde ejaculation and anejaculation are diagnoses.” [46]
Retrograde ejaculation: what it is and how it’s recognized
In retrograde ejaculation, patients may feel a normal orgasm but have minimal or no visible semen. Major clinical resources describe confirming the diagnosis by evaluating urine for sperm after orgasm; if a high volume of sperm is found in urine, retrograde ejaculation is supported. [47]
Common causes include: – Surgery or procedures involving prostate/bladder neck (classic example: TURP). – Neurologic dysfunction (e.g., diabetes-related autonomic neuropathy). – Medications that impair bladder neck closure (e.g., some alpha blockers). [48]
Anejaculation: what it is and why semen doesn’t enter the urethra
In anejaculation, semen is not successfully emitted into the urethra. The symptom can resemble retrograde ejaculation (little/no semen), but urine may not show sperm. The Cleveland Clinic[49] describes anejaculation as orgasm occurring without semen release. [50]
Neurogenic causes (spinal cord injury, certain surgeries, neuropathies) are important, and the European Association of Urology[43] guideline discusses interventions such as penile vibratory stimulation and electro-ejaculation in selected contexts. [51]
Other reasons semen volume may be very low
“Little semen” (hypospermia) and “no semen” can also result from: – Incomplete collection (very common and often unrecognized by patients). – Androgen deficiency (can reduce accessory gland secretion). – Ejaculatory duct obstruction or congenital anomalies affecting seminal vesicles/vas deferens, which can reduce volume and alter pH/fructose patterns. [52]
For patients: one”low volume” test does not equal permanent dysfunction. Repeat testing under correct conditions is often the first step. [53]
How to give a representative semen analysis sample
This section is written intentionally as a practical, clinic-ready set of instructions for patients, with clinician-focused rationale embedded.
Abstinence time: how many days?
For routine semen analysis, the sixth edition World Health Organization[27] manual recommends collection after a minimum of 2 days and a maximum of 7 days of ejaculatory abstinence. [54]
Many laboratories provide a slightly narrower window (often 2–5 days) to standardize testing, and patient instruction sheets commonly reflect this. For example, New York Cryo [55] patient instructions recommend avoiding sexual activity for 2–3 days before collection. [56]
How to explain the “why” to patients: abstinence affects semen volume and sperm numbers; too short an interval can reduce total sperm per ejaculate, and very long abstinence may increase sperm numbers but can worsen some functional measures in some men. This is why a standardized abstinence window matters for comparability. [57]
Collection method and container
The WHO manual’s core recommendations include: – Collect by masturbation when possible. – Avoid lubricants because they can contaminate the ejaculate and change properties; if absolutely necessary, only use validated non-spermatotoxic products. – Ensure the entire ejaculate is collected; report any loss of any fraction. [58]
Container guidance from WHO is specific: – Use a clean, wide-mouthed plastic container from a batch confirmed to be non-toxic for spermatozoa. – Keep the specimen container at ambient temperature 20–37°C to avoid large temperature changes. [59]
Laboratory instruction sheets often mirror this. The Allina Health[55] instructions emphasize collecting into the provided clean container, avoiding lubricants/condoms unless using a non-toxic condom specifically provided for that purpose. [56]
Time and temperature during transport
For classic, unpreserved semen analysis, time is crucial because: – Motility and vitality are labile. – Dehydration and temperature swings can alter sperm function. [60]
The WHO sixth edition guidance recommends: – Ideally begin investigation within 30 minutes after collection, and no longer than 60 minutes. – If collected away from the lab, transport should keep sample temperature between 20°C and 37°C, and the container should be kept close to the body under clothing; delivery is preferably within 30 minutes and not longer than ~50–60 minutes. [61]
Commercial lab logistics commonly echo a one-hour stability window. For example, Labcorp[62] lists room-temperature stability for semen analysis as 1 hour, advising the sample be kept close to the body to avoid temperature extremes during transport. [63]
What changes if the sample is delayed?
The parameter most clearly affected by delay is typically motility (and derived measures like total motile count). A study evaluating motility at multiple timepoints after ejaculation reported significant decreases as the ejaculation-to-analysis interval increased, with statistically significant decline noted by about one hour in that dataset. [64]
The WHO manual also explicitly notes that prolonged in vitro exposure of liquefied semen can affect qualities such as motility and morphology, reinforcing that the “clock starts” at collection. [65]
At the same time, laboratories can sequence some steps: the WHO workflow notes that some tasks (e.g., sperm concentration determination) can occur later (preferably same day), and morphology staining can be done later after smear preparation—this is a lab workflow point, not a reason to delay collection/transport. [31]
What if someone ships the sample overnight?
For a standard semen analysis performed on fresh, unpreserved semen, overnight shipping is generally not compatible with the classic WHO time-to-analysis expectation (start within 30–60 minutes) because temperature fluctuations and time-dependent declines can distort key functional metrics—especially motility. [66]
However, there is an important nuance: some mail-in services do not attempt a “standard fresh semen analysis.” Instead, they use validated preservation media and controlled temperature shipping to produce results that correlate with near-immediate testing under specified conditions.
A 2024 validation study (using split specimens) evaluated semen parameters analyzed at <1 hour versus ~26 hours using a proprietary delayed analysis medium and a monitored shipping protocol. In controlled settings, motility, concentration, and morphology showed high consistency between 1-hour and 26-hour analyses; in real-world commercial shipment, variation increased but remained within ranges the authors compared favorably to inter-laboratory variation in proficiency testing. This supports that a delayed-analysis service can be valid when specifically engineered and validated, but it should not be conflated with “just mailing in a regular specimen cup.” [67]
How to phrase this for patients:
– “If your lab asked for a sample within 1 hour, mailing it overnight is likely to give misleading motility results.” [68]
– “If you are using a mail-in kit, follow that kit’s instructions exactly, because it may be a different, validated method with preservatives and temperature control.” [67]
For clinicians: emphasize documentation. If a patient reports a long transport time, that information should accompany interpretation—especially for motility-dependent counseling. [69]
References
- World Health Organization[27]. WHO laboratory manual for the examination and processing of human semen. 6th ed. Geneva: World Health Organization; 2021. [70]
- Holstein AF[71], Schulze W[72]. Understanding spermatogenesis is a prerequisite for treatment. Reproduction. 2003;126(2):149-162. [1]
- Griswold MD[73]. Spermatogenesis: the commitment to meiosis. Physiol Rev. 2016;96(1):1-17. [74]
- O’Donnell L[75], Smith LB[76]. Endocrinology of the testis and spermatogenesis. In: Endotext[Internet]. South Dartmouth (MA): MDText.com, Inc.; updated 2026. [77]
- Ramaswamy S[78], Weinbauer GF[79]. Endocrine control of spermatogenesis: role of FSH and LH/testosterone. Ann N Y Acad Sci. 2015;1354:38-50. [80]
- Revenig LM[81], Leung A[82], Hsiao W[83]. Ejaculatory physiology and pathophysiology: assessment and treatment in male infertility. Transl Androl Urol. 2014;3(1):41-49. [84]
- Alwaal A[85], Breyer BN[86], Lue TF[87]. Normal male sexual function: emphasis on orgasm and ejaculation. Fertil Steril. 2015;104(5):1051-1060. [88]
- Tomaiuolo G[89], De Luca A[90]. Semen rheology and its relation to male infertility. Eur J Med Res.2022;27:264. [91]
- Jonsson M[92], Linnaeusson T[93]. Semenogelins I and II bind zinc and regulate the activity of prostate-specific antigen. Biochem J. 2005;387(Pt 2):447-453. [94]
- Anamthathmakula P[95], Winters SJ[96]. Mechanism of semen liquefaction and its potential for a novel non-hormonal contraception. Andrology. 2020;8(2):338-351. [97]
- European Association of Urology[43]. EAU Guidelines on Sexual and Reproductive Health: Disorders of Ejaculation. Updated guidance accessed 2026. [98]
- European Association of Urology[43]. EAU Guidelines on Sexual and Reproductive Health: Male Infertility. Updated guidance accessed 2026. [99]
- American Society for Reproductive Medicine[36]. Diagnosis and treatment of infertility in men: AUA/ASRM guideline part I. 2020 (posted 2021). [37]
- Mehta A[100], Sigman M[101]. A systematic review of aspermia and retrograde ejaculation. Fertil Steril. 2015;104(5):1074-1081. [102]
- Mayo Clinic[103]. Retrograde ejaculation: diagnosis and treatment. Updated guidance accessed 2026. [104]
- Cleveland Clinic[49]. Anejaculation: causes, symptoms, diagnosis & treatment. Updated guidance accessed 2026. [105]
- Sunder M[106], Leslie SW[107]. Semen analysis. In: National Library of Medicine[108], National Institutes of Health[109]. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing[110]; updated 2022. [111]
- Racicot K[112], Quest Diagnostics[113]. Validation of a mail-in delayed semen analysis protocol developed for home collection. Fertil Steril. 2024. [67]
- Chomsrimek N[114], Sirisomboon P[115]. Effect of time between ejaculation and analysis on sperm motility. Thai J Obstet Gynaecol. 2008;16(2):110-113. [64]
- Meistrich ML[116]. The effects of chemotherapy and radiotherapy on spermatogenesis in humans. Fertil Steril. 2013;100(5):1180-1186. [117]
- Howell SJ[118], Shalet SM[119]. Spermatogenesis after cancer treatment: damage and recovery. J Natl Cancer Inst Monogr. 2005;(34):12-17. [120]
- Garolla A[121], Pizzol D[122]. Seminal and molecular evidence that sauna exposure affects spermatogenesis and sperm function but is reversible. Hum Reprod. 2013;28(4):877-885. [123]
- Welliver C[124], Lipshultz LI[125]. Analysis of semen parameters during 2 weeks of daily ejaculation: a pilot study. Andrology. 2016;4(6):1082-1086. [126]
- Labcorp[62]. Semen analysis stability requirements (AUA guideline format; Labcorp test listing). Accessed 2026. [63]
- New York Cryo and The Mens Fertility Lab[55]. Semen analysis (patient instructions). 2018. [56]
[1] [6] [9] [10] [27] https://pmc.ncbi.nlm.nih.gov/articles/PMC293421/
https://pmc.ncbi.nlm.nih.gov/articles/PMC293421
[2] [19] [28] [29] [30] [31] [32] [43] [49] [52] [54] [57] [58] [59] [61] [65] [66] [68] [69] [70] [85] [92] [93] [100][103] [110] [114] [116] https://www.micropticsl.com/wp-content/uploads/2021/10/who_laboratory_manual_for_the_examination_and_processing_of_human_semen_sixth_edition.pdf
[3] [8] [12] [20] [26] [35] [37] [38] [53] [55] [73] [86] [90] [107] [113] [119] [121] [122] [125]https://www.asrm.org/practice-guidance/practice-committee-documents/diagnosis-and-treatment-of-infertility-in-men-auaasrm-guideline-part-i-2020/
[4] Review Spermatogenesis in humans and its affecting factors
https://www.sciencedirect.com/science/article/abs/pii/S1084952116301045?utm_source=chatgpt.com
[5] https://academic.oup.com/biolreprod/article/71/5/1405/2666939
https://academic.oup.com/biolreprod/article/71/5/1405/2666939
[7] [11] [13] [39] [77] [106] [118] https://www.ncbi.nlm.nih.gov/books/NBK279031/
https://www.ncbi.nlm.nih.gov/books/NBK279031
[14] [36] [62] https://pmc.ncbi.nlm.nih.gov/articles/PMC9588744/
https://pmc.ncbi.nlm.nih.gov/articles/PMC9588744
[15] [82] [87] [117] https://pmc.ncbi.nlm.nih.gov/articles/PMC3826884/
https://pmc.ncbi.nlm.nih.gov/articles/PMC3826884
[16] [17] [91] [112] https://pmc.ncbi.nlm.nih.gov/articles/PMC9560795/
https://pmc.ncbi.nlm.nih.gov/articles/PMC9560795
[18] [24] [84] [89] [96] [108] https://pmc.ncbi.nlm.nih.gov/articles/PMC4708301/
https://pmc.ncbi.nlm.nih.gov/articles/PMC4708301
[21] [22] [94] https://pmc.ncbi.nlm.nih.gov/articles/PMC1134973/
https://pmc.ncbi.nlm.nih.gov/articles/PMC1134973
[23] [25] [34] [60] [111] [115] https://www.ncbi.nlm.nih.gov/books/NBK564369/
https://www.ncbi.nlm.nih.gov/books/NBK564369
[33] [40] [75] [99] https://uroweb.org/guidelines/sexual-and-reproductive-health/chapter/male-infertility
https://uroweb.org/guidelines/sexual-and-reproductive-health/chapter/male-infertility
[41] [88] https://pmc.ncbi.nlm.nih.gov/articles/PMC4896089/
https://pmc.ncbi.nlm.nih.gov/articles/PMC4896089
[42] [44] [48] [51] [71] [76] [78] [98] https://uroweb.org/guidelines/sexual-and-reproductive-health/chapter/disorders-of-ejaculation
https://uroweb.org/guidelines/sexual-and-reproductive-health/chapter/disorders-of-ejaculation
[45] [102] [109] https://pubmed.ncbi.nlm.nih.gov/26432530/
https://pubmed.ncbi.nlm.nih.gov/26432530
[46] [47] [95] [104] Retrograde ejaculation – Diagnosis & treatment
[50] [81] [105] [124] Anejaculation: Causes, Symptoms, Diagnosis & Treatment
https://my.clevelandclinic.org/health/diseases/23371-anejaculation?utm_source=chatgpt.com
[56] [83] [101] https://www.allinahealth.org/-/media/allina-health/files/medical-services/lab-services/semen-sample-collection-english-15307.pdf
[63] 519013: Semen Analysis (AUA Guidelines), Postvasectomy
[64] https://he02.tci-thaijo.org/index.php/tjog/article/download/82277/pdf_71/198979
https://he02.tci-thaijo.org/index.php/tjog/article/download/82277/pdf_71/198979
[67] https://pmc.ncbi.nlm.nih.gov/articles/PMC11705597/
https://pmc.ncbi.nlm.nih.gov/articles/PMC11705597
[72] [120] https://academic.oup.com/jncimono/article/2005/34/12/905249
https://academic.oup.com/jncimono/article/2005/34/12/905249
[74] [79] Spermatogenesis: The Commitment to Meiosis – PMC
https://pmc.ncbi.nlm.nih.gov/articles/PMC4698398/?utm_source=chatgpt.com
[80] Endocrine control of spermatogenesis: Role of FSH and LH
https://pmc.ncbi.nlm.nih.gov/articles/PMC4581062/?utm_source=chatgpt.com
[97] Mechanism of semen liquefaction and its potential for a novel …
https://pmc.ncbi.nlm.nih.gov/articles/PMC7523691/?utm_source=chatgpt.com
[123] https://pubmed.ncbi.nlm.nih.gov/23411620/
https://pubmed.ncbi.nlm.nih.gov/23411620
[126] https://pmc.ncbi.nlm.nih.gov/articles/PMC5071206/
https://pmc.ncbi.nlm.nih.gov/articles/PMC5071206
RELATED ARTICLES: